Business Insider6d
IceCure's ProSense System Gets FDA Panel's Favorable Vote For Low Risk Breast Cancer Treatment
(RTTNews) - IceCure Medical Ltd. (ICCM), Friday announced that the U.S. Food and Drug Administration's Advisory panel has voted in favor of the company's ProSense technology intended for early ...
Nasdaq6d
IceCure Medical announces FDA’s favorable recommendation for ProSense
The majority of panelists voted that the benefits of IceCure’s ProSense System outweigh the risks when used according to the proposed indications for the treatment of patients with early-stage ...
Yahoo Finance6d
FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
"This is a significant milestone on the path towards the marketing authorization of ProSense® cryoablation in the U.S. for early-stage low risk breast cancer and I believe a critically important ...
Business Insider5d
Icecure Medical’s ProSense System Gains Favorable FDA Panel Recommendation and Strong Financial Position Supports Buy Rating
Anthony Vendetti has given his Buy rating due to a combination of factors. Firstly, Icecure Medical’s ProSense System received a favorable recommendation from the FDA Medical Device Advisory ...